News Conference News EuroPCR 2012 Mixed Results Shown with Adenosine-Free Pressure Measurement vs. FFR Jason Kahn May 16, 2012
News Conference News EuroPCR 2012 FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy Caitlin E. Cox May 15, 2012
News Industry News Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy May 11, 2012
News Industry News New Data From Landmark Study Shows Cost-Effectiveness of Medtronic Life-Saving CRT-D Therapy in Mildly Symptomatic Heart Failure Patients May 11, 2012
News Daily News FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel Caitlin E. Cox May 09, 2012
News Daily News High Prasugrel Reloading Dose Best for Suppressing Platelet Reactivity Prior to PCI Jason Kahn May 01, 2012
News Daily News Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity April 25, 2012
News Daily News TRIGGER-PCI Published: Halted Trial Questions Platelet Testing in Stable Patients April 19, 2012
News Daily News Exenatide Only Cardioprotective in STEMI Patients Treated Quickly Caitlin E. Cox April 16, 2012
News Daily News JAMA Letters Continue Debate Over Genotype, Clopidogrel Response Caitlin E. Cox April 12, 2012
News Daily News CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact April 10, 2012
News Daily News Rapid Bedside Genotyping May Help Guide Antiplatelet Strategy After PCI Caitlin E. Cox March 30, 2012
News Conference News ACC 2012 Symplicity Works: Renal Denervation Reduces Resistant Hypertension Yael L. Maxwell March 27, 2012
News Conference News ACC 2012 Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism L.A. McKeown March 26, 2012
News Industry News Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients March 26, 2012
News Conference News ACC 2012 INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI Jason Kahn March 25, 2012
News Conference News ACC 2012 Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES Jason Kahn March 24, 2012